Monthly Newsletter

Oxford Global Conferences are proud to present the Biosimilars Asia Congress taking place on 24th &  25th September 2013 in Singapore. The congress is dedicated to the most pressing challenges and critical opportunities in the biosimilars sector, creating a focused platform for scientific debate and executive-level networking.

As the only conference to bring together all the experts in the global biopharmaceutical industry, this exciting and important meeting is a must for anyone working in the field of biosimilars and biobetters.

Over the two days, the event will attract over 175 senior-level decision makers from Europe, the US and Asia with a comprehensive conference program featuring two separate streams, key note addresses, case study presentations and interactive panel discussions given by expert speakers from global pharmaceutical organisations and leading research institutions.

On Day One our panel of biosimilars experts will explore key strategies for gaining market entry, managing the role of innovator companies and commercialising biosimilars. Our internationally renowned speakers will also discuss the critical issues in manufacturing biosimilars, achieving quality by design, single use systems and the Mab biosimilar opportunity.

Day Two will feature case studies of the opportunities and challenges in clinical trials including implications for clinical development and patient safety. Do not miss out gaining the latest insights into developing an efficient scale up process, demonstrating biosimilarity and CMC considerations.

The event will be co-located with the Cell Culture Asia Congress, a high level meeting focused on cell line development, cell culture, bioprocessing and bioproduction.

For further information click here